Cumberland Q4 Loss Narrows Y/Y as Talicia Launch Boosts Sales
Shares of Cumberland Pharmaceuticals Inc. CPIX have declined 29.5% since reporting results for the fourth quarter of 2025. This compares with the S&P 500 index’s 2% fall over the same time frame. Over the past month, the stock has lost 11.9% compared with the S&P 500’s 3% dip. For the fourth quarter of 2025, Cumberland ...












